←
Matt Dukewich, MD, PharmD6 posts
Matt Dukewich, MD, PharmD avatar

Matt Dukewich, MD, PharmD

@MDukewich

T32 GI/Liver Fellow, University of Southern California Clinical epidemiology, steatotic liver disease

◷ Joined February 2024
Lily Dara avatar
⟳ Matt Dukewich, MD, PharmD retweeted
Lily Dara@lilydaramd·5 Apr 2024

How big a problem is post LT EtOH use? @USC_KeckGILiver Drs. Brian P Lee and Matt Dukewich @MDukewich report data from the accelerate cohort: 80% pts remain abstinent post LT, of the 20% that relapse those that re-abstain and stop drinking for 12m after one relapse have good outcomes. Addiction is a chronic disease and we need to keep reinforcing the importance of #abstinence @CLDFoundation #liverconnect @KeckMedicineUSC #livertwitter #gitwitter @AyyalaDivya @norahterrault @HelenHanMD @JeffreyAKahn @melanie_a_hundt @howiethedoc @kalizhouMD @AniKardashianMD

Post attachmentPost attachment